Mechanisms of blood-brain barrier dysfunction in neurodegenerative disease

Project Information

BLOOD-BRAIN BARRIER

Grant agreement ID: QLK6-CT-2001-60002

Project closed

Start date 13 September 2002

End date 12 September 2006

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 84 672,00

EU contribution € 84 672,00

Coordinated by

SMITHKLINE BEECHAM PLC
United Kingdom

Objective

An investigation into the cellular mechanism(s) underlying blood-brain barrier (BBB) dysfunction in neurodegenerative disorders, with particular emphasis on the role of mast cells and inflammatory mediators in BBB breakdown.

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Call for proposal

Data not available

Funding Scheme

BUR - Bursaries, grants, fellowships

Coordinator

SMITHKLINE BEECHAM PLC

• EU contribution: No data
• Address: New Horizons Court ; TW8 9EP BRENTFORD ; United Kingdom
• Total cost: No data